News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trevena, Inc. (TRVN) Appoints Robert Prachar As Senior Vice President, Commercial And Corporate Strategy


4/1/2014 7:11:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free 

GenePool newsletter today!

Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the appointment of Robert Prachar to the newly created position of Senior Vice President, Commercial and Corporate Strategy, effective immediately. Mr. Prachar, who has served as a full-time consultant for the Company since August 2013, brings over 20 years of commercial leadership experience in the life sciences industry.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES